FDA Approval: ZYVOX (LINEZOLID) — Type 3 - New Dosage Form
Policy FDA-NDA021131 · Infectious Disease
ZYVOX (Linezolid) is an injectable drug likely to receive a J-code assignment for billing. It will be billed under Part B, and potential ASP+6% payment may apply due to its injectable nature.